Search Share Prices
AZN Headlines - AstraZeneca scores another late-stage win, this time with COPD drug
was shown to be much more effective in reducing the number of exacerbations suffered by COPD patients than current drugs Astra has enjoyed successes in a number of studies of late AstraZeneca PLC (LON ...
We Think AstraZeneca (LON:AZN) Can Stay On Top Of Its Debt
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's balance sheet when you examine how risky it is, since debt is often involved ...
Amryt Pharma: The AIM drug developer potentially sitting on a US$100mln piece of paper
Amryt has a chance of being awarded a priority review voucher, which sell for several times more than the company’s current market cap AstraZeneca PLC’s (LON:AZN) US$95mln deal to buy a priority ...
FTSE 100 led higher by Sainsbury's after release of grocery market share data
“This is the sugar high that is cushioning the market from continued uncertainty.” On the market, AstraZeneca (LON:AZN) topped the leader board with a 1.7% gain following another clinical trial ...
Broker Forecast - Barclays Capital issues a broker note on AstraZeneca PLC
StockMarketWire.com - Barclays Capital today reaffirms its overweight investment rating on AstraZeneca PLC [LON:AZN] and raised its price target to 7800p (from 7600p).